Effective Treatment against ESBL-Producing Klebsiella pneumoniae through Synergism of the Photodynamic Activity of Re (I) Compounds with Beta-Lactams.
Iván A GonzálezAnnegrett PalavecinoConstanza NúñezPaulina DreyseFelipe Melo-GonzálezSusan M BuenoChristian Erick PalavecinoPublished in: Pharmaceutics (2021)
Compounds PSRe-µL1 and PSRe-µL2 produce an effective and synergistic aPDI effect on KPC+, ESBL, and clinical isolates of K. pneumoniae and have low cytotoxicity in mammalian cells.